Abstract

Transforming growth factor-beta1 (TGF-β1) is a major factor in pathogenesis of chronic hepatic injury. Carbon tetrachloride (CCl4) is a liver toxicant, and CCl4-induced liver injury in mouse is a classical animal model of chemical liver injury. However, it is still unclear whether TGF-β1 is involved in the process of CCl4-induced acute chemical liver injury. The present study aimed to evaluate the role of TGF-β1 and its signaling molecule Smad3 in the acute liver injury induce by CCl4. The results showed that CCl4 induced acute liver injury in mice effectively confirmed by H&E staining of liver tissues, and levels of not only liver injury markers serum ALT and AST, but also serum TGF-β1 were elevated significantly in CCl4-treated mice, compared with the control mice treated with olive oil. Our data further revealed that TGF-β1 levels in hepatic tissue homogenate increased significantly, and type II receptor of TGF-β (TβRII) and signaling molecules Smad2, 3, mRNA expressions and Smad3 and phospho-Smad3 protein levels also increased obviously in livers of CCl4-treated mice. To clarify the effect of the elevated TGF-β1/Smad3 signaling on CCl4-induced acute liver injury, Smad3 in mouse liver was overexpressed in vivo by tail vein injection of Smad3-expressing plasmids. Upon CCl4 treatment, Smad3-overexpressing mice showed more severe liver injury identified by H&E staining of liver tissues and higher serum ALT and AST levels. Simultaneously, we found that Smad3-overexpressing mice treated with CCl4 showed more macrophages and neutrophils infiltration in liver and inflammatory cytokines IL-1β and IL-6 levels increment in serum when compared with those in control mice treated with CCl4. Moreover, the results showed that the apoptosis of hepatocytes increased significantly, and apoptosis-associated proteins Bax, cytochrome C and the cleaved caspase 3 expressions were up-regulated in CCl4-treated Smad3-overexpressing mice as well. These results suggested that TGF-β1/Smad3 signaling was activated during CCl4-induced acute liver injury in mice, and Smad3 overexpression aggravated acute liver injury by promoting inflammatory cells infiltration, inflammatory cytokines release and hepatocytes apoptosis. In conclusion, the activation of TGF-β signaling contributes to the CCl4-induced acute liver injury. Thus, TGF-β1/Smad3 may serve as a potential target for acute liver injury therapy.

Highlights

  • Transforming growth factor-beta (TGF-β) superfamily, which includes TGF-β, inhibins, activin and bone morphogenetic protein (BMP), possesses a wide range of biological function

  • The results revealed that levels of ALT and AST in sera of mice were significantly elevated on days 1 and 3 after the administration of CCl4, compared with those in control mice treated with olive oil (Fig 2A), and the increased peak was on day 1, and gradually declined

  • The results revealed that TGF-β1 levels increased significantly in sera of CCl4-treated mice, compared with those in control mice treated with olive oil (Fig 2B), and the levels peaked on day 1 and 3

Read more

Summary

Introduction

Transforming growth factor-beta (TGF-β) superfamily, which includes TGF-β, inhibins, activin and bone morphogenetic protein (BMP), possesses a wide range of biological function. They play critical roles in early embryogenesis, neuronal differentiation induction, hematopoiesis and osteoblast proliferation and differentiation [1,2,3,4]. Signaling is initiated with TGF-β/TGF-β type II receptor (TβRII) binding and subsequently, type I receptor (TβRI) is activated. Smad is an important TGF-β signaling molecule [14] and exerts important roles in activation of hepatic stellate cells, inducing them to produce concomitant extracellular matrix [15, 16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call